Transient Global Amnesia

David Sealy, MD
Robert J. Tiller, MD
Katherine Johnson, MD

American Family Physician. 2022;105(1):50-54.

Author disclosure: No relevant financial relationships.

Transient global amnesia (TGA) is a clinical syndrome characterized by anterograde amnesia, mild retrograde amnesia, and confusion up to 24 hours. Most commonly seen in patients older than 50 years, TGA results from the temporary impairment of short-term memory formation. Clinically, patients have time disorientation and often ask repeated questions regarding the day's events. Vomiting, headache, blurry vision, dizziness, and nausea may be present. A physically or psychologically stressful precipitating event, such as emotional stress, significant physical exertion, exposure to extreme temperatures, high-altitude conditions, Valsalva maneuver, acute illness, or sexual intercourse, is often the cause. The pathophysiology of TGA is not well understood but may be related to impaired venous drainage of the hippocampus. The diagnosis is primarily clinical, but recent studies suggest that magnetic resonance imaging may be helpful. TGA is self-limited and resolves within 24 hours. There is no established treatment for episodes. The lifetime recurrence rate is 2.9% to 23.8%. Recent evidence suggests an association between TGA and migraine headaches as well as takotsubo cardiomyopathy. No apparent increased risk of cerebrovascular events occurs in patients who have had an episode of TGA. There is conflicting evidence as to whether an episode of TGA predisposes to future seizures or dementia.

Transient global amnesia (TGA) is characterized by the sudden onset of transient, anterograde amnesia without further focal neurologic deficits.16 Mental status is overall normal but may include mild confusion.1,2 Research suggests that the diagnosis is missed 90% of the time at initial presentation, often resulting in extensive and perhaps unnecessary evaluations.3

SORT: KEY RECOMMENDATIONS FOR PRACTICE

TGA = transient global amnesia.

A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.

Epidemiology

The incidence of TGA is three to eight cases per 100,000 person years but increases to 23.8 cases per 100,000 in patients older than 50 years.2,46 A TGA episode is often preceded by a recent stressful physical or psychological event, with reports in the literature ranging from 52% to 89%.47 The most frequently cited precipitating events include acute illness, medical procedures, significant physical exertion, sexual intercourse, high-altitude environment, extreme temperatures, and Valsalva maneuver. 57 Triggering emotional events can be positive or negative; TGA has been associated with birth announcements, news of suicide, and in patients learning of worsening health troubles, family concerns, financial pressures, and higher-stress urban living situations.2,68

A history of migraine headache is the only diagnosis definitively associated with TGA, with a relative risk of 5.98.9,10 This is most prevalent among women 40 to 60 years of age.9,10 Other recent data suggest a higher rate of TGA in patients with hypertension and hyperlipidemia.11 Case reports of takotsubo cardiomyopathy happening concurrently with TGA have occurred, with an odds ratio of 2.3 in a cross-sectional study of U.S. hospitalizations.12 There have been additional reports of troponin I elevations or other concomitant cardiac events in the setting of TGA.13 Reports of TGA associated with severe COVID-19 have recently appeared, suggesting that the hypercoagulable state of COVID-19 may precipitate thrombotic strokes in the hippocampus.14 One case-control study demonstrated a relative risk of 8.4 for TGA associated with obstructive sleep apnea.15

Presentation

Patients may have nausea, vomiting, headache, mild dizziness, or subjective visual blurring.1,2,4 Patients with TGA report feeling disoriented to time and believe that something is wrong with them.1,2 This disorientation and sensation occur because of the patient's inability to encode new information with their episodic (short-term) memory. During the TGA episode, patients commonly ask repetitive questions such as “Where am I?” or “How did I get here?” Due to maintained procedural memory, learned functions such as eating, language, and driving are not impaired. TGA may last less than an hour, usually resolves within six hours, and always resolves within 24 hours.2,16 The diagnostic criteria require that the episode be witnessed by reliable people present for most of the episode, with no reported seizure activity or recent head trauma in the patient as well as all other criteria in Table 1.1

TABLE 1. Diagnostic Criteria for Transient Global Amnesia

Anterograde amnesia must occur during the episode
Cognitive impairment is limited to amnesia
Episode must resolve within 24 hours
Episode must be witnessed by a reliable witness
No clouding of the consciousness or loss of personal identity occurs
No focal neurologic signs or symptoms occur
No occurrence of recent head injury or active seizures

Information from reference 1.

Differential Diagnosis

Other diagnoses should be considered when evaluating a patient with symptoms of amnesia. Another rare diagnosis with symptoms similar to TGA is transient epileptic amnesia. However, transient epileptic amnesia presents with short, rapid recurrences of amnesia attributable to seizure activity. Other disorders include undiagnosed concussion, metabolic or infectious encephalopathy, delirium, benzodiazepine or alcohol intoxication, encephalitis, and nonconvulsive status epilepticus.2,17,18 Atypical migraine or psychiatric disorders, such as conversion disorder or dissociative amnesia, may also be considered. Most of these diagnoses can be excluded with careful consideration of the historical presentation and a complete physical and neurologic examination. TGA is characterized by spontaneous return to baseline function, typically within hours of the event. Dissociative amnesia will often last for days or longer and be in the context of underlying psychiatric diagnoses. If nausea and dizziness are pervasive with the amnesia, consider vertebrobasilar insufficiency (Table 2).

TABLE 2. Differential Diagnosis of Transient Anterograde Amnesia

DiagnosesRisk factorsPrecipitating factorsDurationAssociated neurologic symptomsMagnetic resonance imagingElectroencephalographyRecurrence of episodes
Cerebrovascular accident/transient ischemic attackMany (e.g., atrial fibrillation, diabetes mellitus, dyslipidemia, hypertension, smoking)NoMinutes to permanent impairmentUsuallyPositive DWI with T2 fluid-attenuated inversion recovery lesionNormal or slowingLow
Migraine headacheGenetic, dietaryYes, numerous triggersFour to 72 hoursAuras (visual, sensory, motor, or language abnormalities) up to 30%; occasional transient focal paralysisNormalNormalHigh
Transient epileptic amnesiaNoneYes (waking)Less than 60 minutes (often, only a few minutes)Yes (oral automatism, olfactory or gustatory hallucinations)Normal/hippocampal sclerosis or atrophyAbnormal (temporal or frontotemporal regions)High
Transient global amnesiaMigraineYesUp to 24 hoursVisual blurringHippocampal DWI hyperintensity or normalNormalLow
Vertebrobasilar insufficiencyVascular (e.g., atrial fibrillation, diabetes mellitus, dyslipidemia, hypertension, smoking)NoLess than 24 hoursYesIschemic lesions in hippocampusNo, or slowingRare

DWI = diffusion-weighted imaging.

Evaluation

Although TGA is diagnosed clinically, a thorough history and physical examination must be completed, and a complete blood count with differential and a complete metabolic panel, including liver function tests, C-reactive protein, ammonia level, erythrocyte sedimentation rate, urine toxicology, serum ethanol level, and thyroid-stimulating hormone, should be considered to exclude other etiologies. Although magnetic resonance imaging is not required to make the diagnosis of TGA, in the first 24 hours of symptom onset, there have been documented transient abnormalities on diffusion-weighted imaging appearing as bright punctate lesions in the hippocampus,6,1820 and 93% of patients will demonstrate hippocampal lesions within 12 to 24 hours of amnesia onset.18 Lesions generally begin to disappear after 72 hours and achieve complete resolution within 10 days.2,18 An additional benefit of magnetic resonance imaging is in establishing or ruling out other causes of transient amnesia, including cortical or vertebrobasilar cerebrovascular accident, in which case magnetic resonance angiography should be considered. Computed tomography, electroencephalography, and positron emission tomography do not show findings specific to TGA.20,21

Pathophysiology

Short-term memory formation is centered around the hippocampus, and isolated injury to this region has been suspected in TGA. Events that increase intrathoracic pressure are associated with TGA and may cause jugular venous hypertension, suggesting that impedance of venous drainage from the hippocampus is involved. Impedance of venous drainage is hypothesized to cause transient ischemia from secondary poor perfusion and sludging.2225 The association between migraine headache and TGA has not been clarified, but hippocampal migraine vascular changes have been hypothesized. The increased prevalence in older patients suggests that age-associated intracerebral changes, especially vascular changes, may increase the risk of TGA. However, individuals with a history of cerebrovascular accident, hypertension, dyslipidemia, coronary artery disease, atrial fibrillation, peripheral vascular disease, or smoking do not have an increased risk of TGA.26

Management

If the presentation is clear and the diagnosis is not in question, no specific intervention is necessary other than reassurance.3,6 Most patients presenting with TGA will recover within six hours and do not require imaging if they fit the diagnostic criteria.3,6 If the diagnosis is in question, then further evaluation is appropriate. If the patient presents before the resolution of amnesia, workup is essentially mandatory (Figure 1).

FIGURE 1.

Algorithm for evaluating sudden-onset anterograde amnesia.

Prognosis

The prognosis of TGA is uniformly good. Population-based studies do not demonstrate an increased risk of cerebrovascular accident after an episode of TGA.27 Some retrospective studies suggest an increased subsequent risk of dementia28 and seizure,29 but older studies do not agree. The published TGA recurrence rate ranges from 2.9% to 23.8%.1,2 The largest retrospective study on TGA indicated that the recurrence rate is increased for patients with a history of migraines, a family history of migraine, or onset of the initial episode at younger than 50 years.26

Data Sources: A PubMed search was conducted multiple times from 2018 through January 2021, with key words transient global amnesia, transient amnesia, migraine and amnesia, transient epileptic amnesia, and diffusion-weighted imaging. Additional searches included our local MRI database, the Cochrane Database of Systematic Reviews, and Essential Evidence Plus. Search date: September 11, 2021.

DAVID SEALY, MD, FAAFP, FAMSSM, is founder and faculty of the Self Regional Healthcare Primary Care Sports Medicine Fellowship and a professor in the Department of Family Medicine at the Medical University of South Carolina, Greenwood.

ROBERT J. TILLER, MD, FAAFP, is director of the Self Regional Healthcare Family Medicine Residency Program and an associate professor in the Department of Family Medicine at the Medical University of South Carolina.

KATHERINE JOHNSON, MD, is a faculty member at the Self Regional Healthcare Family Medicine Residency Program and an assistant professor in the Department of Family Medicine at the Medical University of South Carolina.

Address correspondence to David Sealy, MD, FAAFP, FAMSSM, Self Regional Healthcare, 155 Academy Ave., Greenwood, SC 29646 (email: dsealy@selfregional.org). Reprints are not available from the authors.

Author disclosure: No relevant financial relationships.

  1. 1.Hodges JR, Warlow CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neurol Neurosurg Psychiatry. 1990;53(10):834-843.
  2. 2.Arena JE, Rabinstein AA. Transient global amnesia. Mayo Clin Proc. 2015;90(2):264-272.
  3. 3.Hoyer C, Ebert A, Pooyeh A, et al.; Shedding light on the clinical recognition process of transient global amnesia. Eur J Neurol. 2020;27(10):1821-1824.
  4. 4.Hunter G. Transient global amnesia. Neurol Clin. 2011;29(4):1045-1054.
  5. 5.Kirshner HS. Transient global amnesia: a brief review and update. Curr Neurol Neurosci Rep. 2011;11(6):578-582.
  6. 6.Spiegel DR, Smith J, Wade RR, et al.; Transient global amnesia: current perspectives. Neuropsychiatr Dis Treat. 2017;13:2691-2703.
  7. 7.Quinette P, Guillery-Girard B, Dayan J, et al.; What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain. 2006;129(pt 7):1640-1658.
  8. 8.Govoni V, Cesnik E, Ferri C, et al.; The distribution of the transient global amnesia in the province of Ferrara, Italy, a clue to the pathogenesis?. Neurol Sci. 2021;42(5):1821-1826.
  9. 9.Yi M, Sherzai AZ, Ani C, et al.; Strong association between migraine and transient global amnesia. J Neuropsychiatry Clin Neurosci. 2019;31(1):43-48.
  10. 10.Lin K-H, Chen Y-T, Fuh J-L, et al.; Migraine is associated with a higher risk of transient global amnesia: a nationwide cohort study. Eur J Neurol. 2014;21(5):718-724.
  11. 11.Arena JE, Brown RD, Mandrekar J, et al.; Long-term outcome in patients with transient global amnesia: a population-based study. Mayo Clin Proc. 2017;92(3):399-405.
  12. 12.Morris NA, Chatterjee A, Adejumo OL, et al.; The risk of Takotsubo cardiomyopathy in acute neurological disease. Neurocrit Care. 2019;30(1):171-176.
  13. 13.Eisele P, Baumann S, Noor L, et al.; Interaction between the heart and the brain in transient global amnesia. J Neurol. 2019;266(12):3048-3057.
  14. 14.Ramanathan RS, Wachsman A. Coronavirus disease-19 (COVID-19) related acute stroke causing transient global amnesia. J Stroke Cerebrovasc Dis. 2021;30(5):105738.
  15. 15.Buratti L, Petrelli C, Potente E, et al.; Prevalence of obstructive sleep apnea syndrome in a population of patients with transient global amnesia. Sleep Med. 2017;32:36-39.
  16. 16.Romoli M, Tuna MA, Paciaroni M, et al.; Time trends, frequency, characteristics and prognosis of short-term duration transient global amnesia. Eur J Neurol. 2020;27(5):887-893.
  17. 17.Pantoni L, Bertini E, Lamassa M, et al.; Clinical features, risk factors, and prognosis in transient global amnesia: a follow-up study. Eur J Neurol. 2005;12(5):350-356.
  18. 18.Szabo K, Hoyer C, Caplan LR, et al.; Diffusion-weighted MRI in transient global amnesia and its diagnostic implications. Neurology. 2020;95(2):e206-e212.
  19. 19.Bartsch T, Alfke K, Deuschl G, et al.; Evolution of hippocampal CA-1 diffusion lesions in transient global amnesia. Ann Neurol. 2007;62(5):475-480.
  20. 20.Pearce MC, Choy G, Chen RC. Clinics in diagnostic imaging (188). Transient global amnesia (TGA). Singapore Med J. 2018;59(7):351-355.
  21. 21.Imperatori C, Farina B, Todini F, et al.; Abnormal EEG power spectra in acute transient global amnesia: a quantitative EEG study. Clin EEG Neurosci. 2019;50(3):188-195.
  22. 22.Cejas C, Cisneros LF, Lagos R, et al.; Internal jugular vein valve incompetence is highly prevalent in transient global amnesia. Stroke. 2010;41(1):67-71.
  23. 23.Agosti C, Borroni B, Akkawi NM, et al.; Cerebrovascular risk factors and triggers in transient global amnesia patients with and without jugular valve incompetence: results from a sample of 243 patients. Eur Neurol. 2010;63(5):291-294.
  24. 24.Himeno T, Kuriyama M, Takemaru M, et al.; Vascular risk factors and internal jugular venous flow in transient global amnesia: a study of 165 Japanese patients. J Stroke Cerebrovasc Dis. 2017;26(10):2272-2278.
  25. 25.Di Filippo M, Calabresi P. Ischemic bilateral hippocampal dysfunction during transient global amnesia. Neurology. 2007;69(5):493.
  26. 26.Morris KA, Rabinstein AA, Young NP. Factors associated with risk of recurrent transient global amnesia. JAMA Neurol. 2020;77(12):1551-1558.
  27. 27.Garg A, Limaye K, Shaban A, et al.; Transient global amnesia does not increase the risk of subsequent ischemic stroke: a propensity score-matched analysis. J Neurol. 2021;268(9):3301-3306.
  28. 28.Hsieh S-W, Chen C-H, Huang P, et al.; The long-term risk of dementia after transient global amnesia: a population-based cohort study in Taiwan. Neuroepidemiology. 2019;53(3–4):201-208.
  29. 29.Hsieh S-W, Yang Y-H, Ho B-L, et al.; The long-term risk of epilepsy after transient global amnesia: a population-based cohort study. Clin Neurol Neurosurg. 2020;197:106086.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.